739596
Last Update Posted: 2016-10-27
Recruiting has ended
All Genders accepted | 18 Years + |
332 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African Americans
The purpose of the study is to evaluate the efficacy and safety of a fixed dose combination of aliskiren HCTZ versus amlodipine in African American patients with Stage 2 hypertension.
Eligibility
Relevant conditions:
Hypertension
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov